These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

560 related items for PubMed ID: 27595699

  • 1. Correlation between liver iron concentration determined by magnetic resonance imaging and serum ferritin in adolescents with thalassaemia disease.
    Chuansumrit A, Laothamathat J, Sirachainan N, Sungkarat W, Wongwerawattanakoon P, Kumkrua P.
    Paediatr Int Child Health; 2016 Aug; 36(3):203-8. PubMed ID: 27595699
    [Abstract] [Full Text] [Related]

  • 2. Reduction of body iron stores to normal range levels in thalassaemia by using a deferiprone/deferoxamine combination and their maintenance thereafter by deferiprone monotherapy.
    Kolnagou A, Kleanthous M, Kontoghiorghes GJ.
    Eur J Haematol; 2010 Nov; 85(5):430-8. PubMed ID: 20662901
    [Abstract] [Full Text] [Related]

  • 3. Comparison of Tissue Elastography With Magnetic Resonance Imaging T2* and Serum Ferritin Quantification in Detecting Liver Iron Overload in Patients With Thalassemia Major.
    Pipaliya N, Solanke D, Parikh P, Ingle M, Sharma R, Sharma S, Sawant P.
    Clin Gastroenterol Hepatol; 2017 Feb; 15(2):292-298.e1. PubMed ID: 27650324
    [Abstract] [Full Text] [Related]

  • 4. Limitations of serum ferritin to predict liver iron concentration responses to deferasirox therapy in patients with transfusion-dependent thalassaemia.
    Porter JB, Elalfy M, Taher A, Aydinok Y, Lee SH, Sutcharitchan P, El-Ali A, Han J, El-Beshlawy A.
    Eur J Haematol; 2017 Mar; 98(3):280-288. PubMed ID: 27859648
    [Abstract] [Full Text] [Related]

  • 5. Uses and limitations of serum ferritin, magnetic resonance imaging T2 and T2* in the diagnosis of iron overload and in the ferrikinetics of normalization of the iron stores in thalassemia using the International Committee on Chelation deferiprone/deferoxamine combination protocol.
    Kolnagou A, Yazman D, Economides C, Eracleous E, Kontoghiorghes GJ.
    Hemoglobin; 2009 Mar; 33(5):312-22. PubMed ID: 19814677
    [Abstract] [Full Text] [Related]

  • 6. [Value of magnetic resonance imaging T2* tests in detecting heart and liver iron overload in patients with β-thalassemia major].
    Wu X, Jing Y, Pei F, Chen J, Feng X, He Y, Zhang Y, Li C.
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):249-52. PubMed ID: 23443782
    [Abstract] [Full Text] [Related]

  • 7. Role of non-invasive assessment in prediction of preclinical cardiac affection in multi-transfused thalassaemia major patients.
    Said Othman KM, Elshazly SA, Heiba NM.
    Hematology; 2014 Oct; 19(7):380-7. PubMed ID: 24225039
    [Abstract] [Full Text] [Related]

  • 8. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
    Voskaridou E, Douskou M, Terpos E, Papassotiriou I, Stamoulakatou A, Ourailidis A, Loutradi A, Loukopoulos D.
    Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of cardiac and hepatic iron overload in thalassemia major patients with T2* magnetic resonance imaging.
    Wahidiyat PA, Liauw F, Sekarsari D, Putriasih SA, Berdoukas V, Pennell DJ.
    Hematology; 2017 Sep; 22(8):501-507. PubMed ID: 28218005
    [Abstract] [Full Text] [Related]

  • 10. MRI for Quantification of Liver and Cardiac Iron in Thalassemia Major Patients: Pilot Study in Indian Population.
    Mandal S, Sodhi KS, Bansal D, Sinha A, Bhatia A, Trehan A, Khandelwal N.
    Indian J Pediatr; 2017 Apr; 84(4):276-282. PubMed ID: 28233255
    [Abstract] [Full Text] [Related]

  • 11. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
    Chirico V, Rigoli L, Lacquaniti A, Salpietro V, Piraino B, Amorini M, Salpietro C, Arrigo T.
    Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
    [Abstract] [Full Text] [Related]

  • 12. Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non-transfusion-dependent thalassaemia.
    Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Origa R, Karakas Z, Habr D, Zhu Z, Cappellini MD.
    Br J Haematol; 2015 Jan; 168(2):284-90. PubMed ID: 25212456
    [Abstract] [Full Text] [Related]

  • 13. Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease.
    Badawy SM, Liem RI, Rigsby CK, Labotka RJ, DeFreitas RA, Thompson AA.
    Br J Haematol; 2016 Nov; 175(4):705-713. PubMed ID: 27507431
    [Abstract] [Full Text] [Related]

  • 14. Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients.
    Christoforidis A, Haritandi A, Tsitouridis I, Tsatra I, Tsantali H, Karyda S, Dimitriadis AS, Athanassiou-Metaxa M.
    J Pediatr Hematol Oncol; 2006 May; 28(5):311-5. PubMed ID: 16772883
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of Iron Overload Between Age Groups Using Magnetic Resonance Imaging and Its Correlation with Iron Profile in Transfusion-dependent Thalassemia.
    Wahidiyat PA, Iskandar SD, Sekarsari D.
    Acta Med Indones; 2018 Jul; 50(3):230-236. PubMed ID: 30333273
    [Abstract] [Full Text] [Related]

  • 16. The impact of liver steatosis on the ability of serum ferritin levels to be predictive of liver iron concentration in non-transfusion-dependent thalassaemia patients.
    Ricchi P, Meloni A, Spasiano A, Costantini S, Pepe A, Cinque P, Filosa A.
    Br J Haematol; 2018 Mar; 180(5):721-726. PubMed ID: 29363758
    [Abstract] [Full Text] [Related]

  • 17. T2* MRI in regularly transfused children with thalassemia intermedia: serum ferritin does not reflect liver iron stores.
    Tony S, Daar S, Elshinawy M, Al-Zadjaly S, Al-Khabori M, Wali Y.
    Pediatr Hematol Oncol; 2012 Sep; 29(6):579-84. PubMed ID: 22839111
    [Abstract] [Full Text] [Related]

  • 18. Myocardial and liver iron overload, assessed using T2* magnetic resonance imaging with an excel spreadsheet for post processing in Tunisian thalassemia major patients.
    Ouederni M, Ben Khaled M, Mellouli F, Ben Fraj E, Dhouib N, Yakoub IB, Abbes S, Mnif N, Bejaoui M.
    Ann Hematol; 2017 Jan; 96(1):133-139. PubMed ID: 27730342
    [Abstract] [Full Text] [Related]

  • 19. Liver iron and serum ferritin levels are misleading for estimating cardiac, pancreatic, splenic and total body iron load in thalassemia patients: factors influencing the heterogenic distribution of excess storage iron in organs as identified by MRI T2*.
    Kolnagou A, Natsiopoulos K, Kleanthous M, Ioannou A, Kontoghiorghes GJ.
    Toxicol Mech Methods; 2013 Jan; 23(1):48-56. PubMed ID: 22943064
    [Abstract] [Full Text] [Related]

  • 20. Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions.
    Chacko J, Pennell DJ, Tanner MA, Hamblin TJ, Wonke B, Levy T, Thomas PW, Killick SB.
    Br J Haematol; 2007 Sep; 138(5):587-93. PubMed ID: 17610536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.